690 Correlates of poor response to neoadjuvant anti-PD-1 therapy in hepatocellular carcinoma (HCC) include WNT pathway activation and loss of HLA expression

Authors :: Kunal Kundu
Nathalie Fiaschi
Wei Wang
Baijun Kou
Assaf Magen
Pauline Hamon
Sacha Gnjatic
Myron Schwartz
Alice Kamphorst
Thomas Marron
Miriam Merad
Chunguang Guo
Gavin Thurston
Namita Gupta
Kamil Cygan
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools